JB Chemicals & Pharmaceuticals ( Part of Rakesh Jhunjhunwala Portfolio) manufacturers of a wide range of innovative specialty medicines for the domestic and international markets, today disclosed a substantial rise in standalone net profit for the quarter ended December 2008. During the quarter, the profit of the company rose 33.45% to Rs 142.40 million from Rs 106.71 million in the same quarter previous year.
Net sales for the quarter jumped 60.45% to Rs 2,230.54 million, while total income for the quarter jumped 51.94% to Rs 2,234.86 million, when compared with the prior year period.
The company posted earnings of Rs 1.69 a share during the quarter, registering 33.07% growth over prior year period.
During the quarter, the operating margin of the company increased by 758.05 basis points to 15.76% compared with the previous year period. Interest cost decreased 7.30% to Rs 35.55 million while depreciation cost rose 23.64% to Rs 51.25 million over previous year period.
Shares of the company gained Rs 0.25, or 0.68%, to settle at Rs 36.75. The total volume of shares traded was 169,919.00 at the BSE (Friday).
As per Dec 08 share holding pattern of JB Chemical, Rakesh Jhunjhunwala has increased his holding from 1,081,650 shares in the name of Jhunjhunwala Rakesh Radheshyam to 1,251,650 shares.